Dr. Belcher says RSV overwhelmed children’s hospitals in 2022 and hit earlier and worse than expected. This year, experts say ...

Federal officials have been working with companies to find ways to boost the supply of the new vaccine for newborns.

Despite 50 years of research, there are currently no RSV vaccines approved or in Phase III trials ... in providing protection to newborns in the first few months of life; Assessing whether passive ...

It is different than a vaccine, said Dr. Shelly Senders, and lasts five to six months and then disappears. "The way that ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ethris’s Phase I trial to investigate its ...

not a vaccine. So once it’s out of the baby’s system, the baby doesn't have any immunity left to RSV. But they are protected during that really vulnerable time. There is another product called RSVpreF ...

Switzerland’s drugs regulator has approved the coronavirus vaccine developed ... afforded seven days after the second injection of the vaccine is over 90 percent. This represents the world's first ...

Those were two main frustrations as EU leaders confronted an array of troubling pandemic developments on Thursday during their first videoconference ... it may simply not be practical. EU approval of ...

RSV vaccines are dwindling as cases continue to rise. Here's what you need to know about the RSV vaccine shortage and how you ...

Medical professionals and politicians like U.S. Sen. Richard Blumenthal this week said people looking to prevent a common respiratory illness that hits hardest among young children and the elderly are ...

Richard Blumenthal chats with employees of InterCommunity Health Care in East Hartford. Blumenthal was there to call for ...

The U.S. senator and several others sent a letter to two RSV vaccine producers, AstraZeneca and Sanofi, asking for answers about shortages and high prices.